Cosmos Health 

€0.2150
72
+€0.00+0.47% Friday 19:55

Statistics

Day High
0.227
Day Low
0.2124
52W High
1.057
52W Low
0.1396
Volume
-
Avg. Volume
-
Mkt Cap
21.64M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

17NovExpected
Q3 2025
Q1 2026
Q2 2026
Next
-0.46
-0.31
-0.16
-0.01
Expected EPS
-0.043095
Actual EPS
N/A

Financials

-28.93%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
56.55MRevenue
-16.36MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow V67A.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap663.28B
Johnson & Johnson is a major competitor in the healthcare sector, offering a wide range of pharmaceutical, medical devices, and consumer health products that compete with Cosmos Health's offerings.
Pfizer
PFE
Mkt Cap162.16B
Pfizer is a global biopharmaceutical company that competes with Cosmos Health in the development and marketing of medications and vaccines for various diseases.
Merck
MRK
Mkt Cap370.89B
Merck & Co., Inc. is a leading pharmaceutical company that develops medicines, vaccines, biologic therapies, and animal health products, competing with Cosmos Health in multiple healthcare areas.
Abbvie
ABBV
Mkt Cap453.19B
AbbVie is a biopharmaceutical company that engages in the discovery, development, manufacture, and sale of a broad range of pharmaceuticals, directly competing with Cosmos Health's product lines.
AMGEN
AMGN
Mkt Cap236.38B
Amgen is a biotechnology company that develops and manufactures innovative human therapeutics, competing with Cosmos Health in the biopharmaceutical sector.
Gilead Sciences
GILD
Mkt Cap187.23B
Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need, competing with Cosmos Health in the healthcare market.
Bristol-Myers Squibb
BMY
Mkt Cap136.49B
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases, competing with Cosmos Health.
Novartis
NVS
Mkt Cap304.1B
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide, competing with Cosmos Health in various therapeutic areas.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics, competing with Cosmos Health in the development of medicines and diagnostics.
Sanofi
SNY
Mkt Cap106.01B
Sanofi is a global healthcare leader that discovers, develops, and distributes therapeutic solutions focused on patients' needs, competing with Cosmos Health in the global healthcare market.

About

Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
Show more...
CEO
Grigorios Siokas
Employees
163
Country
United States
ISIN
US2214133058
WKN
000A3DZZN

Listings

0 Comments

Share your thoughts

FAQ

What is Cosmos Health stock price today?
The current price of V67A.STU is €0.22 EUR — it has increased by +0.47% in the past 24 hours. Watch Cosmos Health stock price performance more closely on the chart.
What is Cosmos Health stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Cosmos Health stocks are traded under the ticker V67A.STU.
Is Cosmos Health stock price growing?
V67A.STU stock has fallen by -6.28% compared to the previous week, the month change is a +21.4% rise, over the last year Cosmos Health has showed a -69.37% decrease.
What is Cosmos Health market cap?
Today Cosmos Health has the market capitalization of 21.64M
When is the next Cosmos Health earnings date?
Cosmos Health is going to release the next earnings report on November 17, 2026.
What were Cosmos Health earnings last quarter?
V67A.STU earnings for the last quarter are -0.09 EUR per share, whereas the estimation was -0.09 EUR resulting in a +0% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Cosmos Health revenue for the last year?
Cosmos Health revenue for the last year amounts to 56.55M EUR.
What is Cosmos Health net income for the last year?
V67A.STU net income for the last year is -16.36M EUR.
How many employees does Cosmos Health have?
As of September 12, 2026, the company has 163 employees.
In which sector is Cosmos Health located?
Cosmos Health operates in the Health & Wellness sector.
When did Cosmos Health complete a stock split?
The last stock split for Cosmos Health was on December 16, 2022 with a ratio of 1:25.
Where is Cosmos Health headquartered?
Cosmos Health is headquartered in THESSALONIKI, United States.